Anke Liebhaber

445 total citations
10 papers, 329 citations indexed

About

Anke Liebhaber is a scholar working on Rheumatology, Hematology and Genetics. According to data from OpenAlex, Anke Liebhaber has authored 10 papers receiving a total of 329 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Rheumatology, 4 papers in Hematology and 2 papers in Genetics. Recurrent topics in Anke Liebhaber's work include Rheumatoid Arthritis Research and Therapies (10 papers), Autoimmune and Inflammatory Disorders Research (4 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Anke Liebhaber is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (10 papers), Autoimmune and Inflammatory Disorders Research (4 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Anke Liebhaber collaborates with scholars based in Germany, Switzerland and Estonia. Anke Liebhaber's co-authors include Karin Rockwitz, Joachim Listing, Anja Strangfeld, A. Zink, Adrian Richter, Siegfried Wassenberg, W. Demary, Kerstin Gerhold, G.-R. Burmester and Anja Weiß and has published in prestigious journals such as Annals of the Rheumatic Diseases, Lara D. Veeken and Arthritis Research & Therapy.

In The Last Decade

Anke Liebhaber

10 papers receiving 316 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anke Liebhaber Germany 7 263 113 84 54 39 10 329
D. Ruiz-Montesinos Spain 7 247 0.9× 77 0.7× 74 0.9× 40 0.7× 35 0.9× 21 317
Inês Guimarães da Silveira Brazil 8 207 0.8× 79 0.7× 40 0.5× 30 0.6× 29 0.7× 19 282
Elaine Yu United States 8 223 0.8× 76 0.7× 79 0.9× 53 1.0× 34 0.9× 15 329
Marios Kouloumas United Kingdom 6 208 0.8× 85 0.8× 54 0.6× 22 0.4× 31 0.8× 8 311
J. Wendler Germany 8 201 0.8× 91 0.8× 97 1.2× 25 0.5× 53 1.4× 26 318
D Hofman Netherlands 4 499 1.9× 207 1.8× 61 0.7× 75 1.4× 73 1.9× 4 544
Fumio Hirano Japan 11 197 0.7× 90 0.8× 83 1.0× 53 1.0× 27 0.7× 27 304
David Vega‐Morales Mexico 10 219 0.8× 56 0.5× 67 0.8× 21 0.4× 43 1.1× 57 305
Carlos Marras Spain 10 216 0.8× 78 0.7× 36 0.4× 32 0.6× 18 0.5× 28 424
Tuomas Rannio Finland 9 183 0.7× 55 0.5× 117 1.4× 23 0.4× 20 0.5× 15 279

Countries citing papers authored by Anke Liebhaber

Since Specialization
Citations

This map shows the geographic impact of Anke Liebhaber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anke Liebhaber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anke Liebhaber more than expected).

Fields of papers citing papers by Anke Liebhaber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anke Liebhaber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anke Liebhaber. The network helps show where Anke Liebhaber may publish in the future.

Co-authorship network of co-authors of Anke Liebhaber

This figure shows the co-authorship network connecting the top 25 collaborators of Anke Liebhaber. A scholar is included among the top collaborators of Anke Liebhaber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anke Liebhaber. Anke Liebhaber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Behrens, Frank, Gerd‐Rüdiger Burmester, Martin Feuchtenberger, et al.. (2022). Characterisation of depressive symptoms in rheumatoid arthritis patients treated with tocilizumab during routine daily care. Clinical and Experimental Rheumatology. 40(3). 551–559. 11 indexed citations
2.
Behrens, Frank, Gerd‐Rüdiger Burmester, Michael W. Hofmann, et al.. (2022). Sustained effectiveness and safety of subcutaneous tocilizumab over two years in the ARATA observational study. Clinical and Experimental Rheumatology. 41(7). 1463–1472. 1 indexed citations
3.
Schäfer, Martin, Katinka Albrecht, Jörn Kekow, et al.. (2020). Factors associated with treatment satisfaction in patients with rheumatoid arthritis: data from the biological register RABBIT. RMD Open. 6(3). e001290–e001290. 17 indexed citations
4.
Keyßer, Gernot, et al.. (2016). Verbesserung der diagnostischen Treffsicherheit bei Patienten mit vermuteter rheumatischer Erkrankung durch Vorselektion in der Früharthritissprechstunde. Zeitschrift für Rheumatologie. 75(8). 812–818. 1 indexed citations
5.
Meißner, Yvette, A. Zink, Jörn Kekow, et al.. (2016). Impact of disease activity and treatment of comorbidities on the risk of myocardial infarction in rheumatoid arthritis. Arthritis Research & Therapy. 18(1). 183–183. 46 indexed citations
6.
Gerhold, Kerstin, Adrian Richter, Matthias Schneider, et al.. (2015). Health-related quality of life in patients with long-standing rheumatoid arthritis in the era of biologics: data from the German biologics register RABBIT. Lara D. Veeken. 54(10). 1858–1866. 47 indexed citations
7.
8.
9.
Detert, J., H. Bastian, Joachim Listing, et al.. (2012). OP0145 Induction therapy with adalimumab plus methotrexate versus methotrexate monotherapy in recent onset rheumatoid arthritis (RA) – an investigator initiated randomized controlled trial. Annals of the Rheumatic Diseases. 71. 102–103. 1 indexed citations
10.
Reichel, Heiko, et al.. (2002). Röntgenologische Veränderungen der Halswirbelsäule bei der rheumatoiden Arthritis: Prognostische Faktoren an Hand einer Querschnittuntersuchung. Zeitschrift für Rheumatologie. 61(6). 710–717. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D. Ruiz-Montesinos Breakdown of academic impact, for papers by Inês Guimarães da Silveira Breakdown of academic impact, for papers by Elaine Yu Breakdown of academic impact, for papers by Marios Kouloumas Breakdown of academic impact, for papers by J. Wendler Breakdown of academic impact, for papers by D Hofman Breakdown of academic impact, for papers by Fumio Hirano Breakdown of academic impact, for papers by David Vega‐Morales Breakdown of academic impact, for papers by Carlos Marras Breakdown of academic impact, for papers by Tuomas Rannio
Rankless by CCL
2026